angiotensin II receptor antagonist
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:ARB
angiotensin receptor blocker |
| gptkbp:contraindication |
pregnancy
bilateral renal artery stenosis |
| gptkbp:discoveredIn |
1990s
|
| gptkbp:effect |
vasodilation
reduced blood pressure |
| gptkbp:example |
gptkb:valsartan
gptkb:telmisartan gptkb:olmesartan gptkb:irbesartan gptkb:losartan candesartan eprosartan |
| https://www.w3.org/2000/01/rdf-schema#label |
angiotensin II receptor antagonist
|
| gptkbp:mechanismOfAction |
blocks angiotensin II type 1 receptor
|
| gptkbp:regulates |
renin-angiotensin-aldosterone system
|
| gptkbp:relatedTo |
ACE inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
renal impairment hyperkalemia |
| gptkbp:usedFor |
heart failure
hypertension chronic kidney disease |
| gptkbp:bfsParent |
gptkb:losartan
|
| gptkbp:bfsLayer |
6
|